Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
Navigation Links
Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
| Products | Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen) | |
| Company | Molecular Probes (Invitrogen) | |
| Item | Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides | |
| Price | ||
| Description | ||
| Info |  Molecular Probes (Invitrogen)PO Box 22010 Eugene, OR 97402-0469
Fax Number: 1-541-344-6504 Web Site: http://probes.invitrogen.com |
1-541-359-2658NOTE: Price information is approximate list price and actual prices may vary.
Related biology products :
1. ELF® 97 Cytological Labeling Kit from CHEMICON
2. ELF 97 Cytological Labeling Kit *with streptavidin alkaline phosphatase conjugate* *50 assays* from Molecular Probes (Invitrogen)
3. Qproteome Nuclear Subfractionation Kit from QIAGEN
4. Nuclear Matrix Protein ELISA Kit from Calbiochem
5. Rabbit Anti-Nuclear Receptor Coactivator 2 (NCOA2) Polyclonal Antibody, Agarose Conjugated from Novus Biologicals
6. Anti-sm (Smith Antigen) (SLE / Nuclear Marker) Ab-1 Monoclonal Antibody, Unconjugated from Lab Vision
7. Nuclear / Cytosol Fractionation Kit from MBL International
8. miRCURY LNA Array microarray slides from Exiqon
9. NIH / 3T3 cell line slides ( mouse: embryo ) from GeneTex
10. P815 cell line slides ( mouse: mast cell; mastocytoma ) from GeneTex
11. L1210 cell line slides ( mouse: lymphocytic leukemia ) from GeneTex
Breaking Biology News(10 mins):Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3IGC scientist receives prestigious EMBO installation grant 2Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 1Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 2Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 3Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 4Apieron Secures Series D Commitments 47445 1Apieron Secures Series D Commitments 47445 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 1For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 3
Other Biology News:Scientists deconstruct cell division 2While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy 2Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 2Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities 3
Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3AEterna Zentaris Announces Appointment of New Board Member 2Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2
[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain[0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease[0] AEterna Zentaris Announces Appointment of New Board Member[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |